science9 min read

How Nootropics Work: Mechanisms of Action Explained

A science-based breakdown of how different nootropic ingredient classes work in the brain — from acetylcholine to NGF to the HPA axis.

The cholinergic system

Acetylcholine is the primary neurotransmitter for attention, learning, and memory encoding. The cholinergic pathway runs from the basal forebrain to the hippocampus and cortex — the exact brain regions involved in forming new memories and sustaining focus. Nootropics enhance cholinergic function in three ways: (1) providing choline precursors (Citicoline, Alpha-GPC, choline bitartrate) that the brain converts to acetylcholine; (2) inhibiting acetylcholinesterase, the enzyme that breaks acetylcholine down (Huperzine A, Bacopa); or (3) increasing the sensitivity of acetylcholine receptors. This is why many premium stacks contain both a choline source and a cholinesterase inhibitor.

The dopaminergic system

Dopamine drives motivation, reward, and working memory. L-Tyrosine is the amino acid precursor that the brain converts to L-DOPA and then dopamine. Under stress, sleep deprivation, or cognitive overload, dopamine and norepinephrine stores are depleted faster than the brain can replenish them — resulting in reduced motivation, poor working memory, and cognitive fatigue. Tyrosine supplementation replenishes the substrate, maintaining performance when conditions are demanding. Adaptogens like Rhodiola Rosea modulate dopamine availability by inhibiting monoamine oxidase (MAO).

The HPA axis and cortisol

The hypothalamic-pituitary-adrenal (HPA) axis governs the stress response. Chronic stress elevates cortisol, which damages hippocampal neurons over time, impairs memory consolidation, and reduces cognitive flexibility. Adaptogens — including Ashwagandha (KSM-66), Rhodiola Rosea, and Panax Ginseng — regulate HPA axis activity, blunting cortisol secretion under acute stress and reducing baseline cortisol over several weeks of use. This is why adaptogens are considered long-term cognitive protectants rather than acute enhancers.

Nerve Growth Factor (NGF) and neurogenesis

Nerve Growth Factor is a protein that promotes the growth, maintenance, and survival of neurons. NGF production declines with age, contributing to memory loss and slower cognitive processing. Lion's Mane mushroom contains hericenones (in the fruiting body) and erinacines (in the mycelium), compounds that stimulate NGF synthesis in the brain. This is why Lion's Mane is one of the few nootropic ingredients with legitimate neuroregeneration potential — though the effects are cumulative and require weeks to months of supplementation to measure.

Alpha brain waves and calm focus

Alpha brain waves (8–12 Hz) are associated with relaxed alertness — the mental state experienced during flow states, meditation, or creative work. L-Theanine, an amino acid from green tea, increases alpha wave amplitude within 30–45 minutes of ingestion. This produces a state of calm focus without sedation. When combined with caffeine, L-theanine blunts the anxiogenic (anxiety-inducing) effects of caffeine while preserving its attention-sharpening and reaction-time benefits — one of the most replicable findings in cognitive neuroscience.

Cell membrane integrity and phospholipids

Neuronal cell membranes are composed largely of phospholipids — primarily phosphatidylserine (PS) and phosphatidylcholine. Healthy membranes are essential for efficient signal transmission between neurons. PS levels in the brain decline naturally from around age 30 onward. Supplementing with PS replenishes membrane composition, improving synaptic signal transduction and facilitating neurotransmitter release. Citicoline works similarly — as a precursor to phosphatidylcholine, it supports membrane repair while simultaneously boosting acetylcholine synthesis.

Nootropics in Australia

Any claim about what a nootropic "does" on an Australian-listed product's label is not free-form marketing copy — it has to match a permitted indication from the TGA's Permissible Indications Determination. The TGA defines indications as statements describing a medicine's claimed purpose or health benefit, and sponsors of AUST L medicines must certify that the wording on their label matches one of these pre-set indications. This gives Australian buyers a reference point that does not exist for products sold without an AUST L number: the specific wording a label is legally permitted to use, separate from whatever the manufacturer's own marketing says about mechanism of action.

What an "indication" is under Australian rules

The TGA explains that 'Indications' are statements that describe the specific therapeutic use for a medicine. They describe a medicine's claimed purpose or health benefit, for example: 'relieves coughs'. It adds that indications can be specific (e.g. refer to a named non-serious condition); or non-specific (e.g. refer to general health maintenance). Every AUST L-listed nootropic's on-label claim is drawn from this defined category, not written freely by the sponsor.

Why the label wording is certified, not just chosen

Listing a medicine involves specific legal certifications. The TGA's guidance states that sponsors of AUST L medicines are also required to certify that proposed indications on your medicine's label are permitted indications under the Permissible Indications Determination. That certification is what ties the words on an Australian nootropic label back to a government-maintained list, rather than to a claim the sponsor invented for that product alone.

Products in Australia

TGA (AUST L)

What counts as an "indication" on an Australian nootropic label?

The TGA defines indications as statements that describe the specific therapeutic use for a medicine, describing a medicine's claimed purpose or health benefit, for example: 'relieves coughs'. Indications can be specific (e.g. refer to a named non-serious condition); or non-specific (e.g. refer to general health maintenance).

Can an AUST L-listed nootropic's label say anything the manufacturer wants about how it works?

No. The TGA's guidance states that sponsors of AUST L medicines are also required to certify that proposed indications on your medicine's label are permitted indications under the Permissible Indications Determination — the wording has to come from that pre-approved list, not from open marketing language.

State & territory guides

Sources: TGA — Permitted indications for listed medicines · TGA — Permitted indications for listed medicines · TGA — Understanding the legislative framework for listed medicines

Regulatory note

Therapeutic goods available in Australia are regulated by the Therapeutic Goods Administration (TGA). AUST L–listed products carry pre-approved permitted indications; AUST R–registered products are higher-evidence. Imported products without TGA listing are not assessed by Australian regulators. This page is editorial, not promotional, and does not constitute medical advice. Always read the label and follow directions for use. Consult a qualified healthcare professional before starting any supplement.

← Back to Guides